1. Home
  2. AXSM vs MCY Comparison

AXSM vs MCY Comparison

Compare AXSM & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • MCY
  • Stock Information
  • Founded
  • AXSM 2012
  • MCY 1961
  • Country
  • AXSM United States
  • MCY United States
  • Employees
  • AXSM N/A
  • MCY N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • MCY Property-Casualty Insurers
  • Sector
  • AXSM Health Care
  • MCY Finance
  • Exchange
  • AXSM Nasdaq
  • MCY Nasdaq
  • Market Cap
  • AXSM 4.2B
  • MCY 3.7B
  • IPO Year
  • AXSM 2015
  • MCY N/A
  • Fundamental
  • Price
  • AXSM $84.60
  • MCY $48.96
  • Analyst Decision
  • AXSM Strong Buy
  • MCY
  • Analyst Count
  • AXSM 14
  • MCY 0
  • Target Price
  • AXSM $125.54
  • MCY N/A
  • AVG Volume (30 Days)
  • AXSM 893.5K
  • MCY 596.8K
  • Earning Date
  • AXSM 02-18-2025
  • MCY 02-11-2025
  • Dividend Yield
  • AXSM N/A
  • MCY 2.60%
  • EPS Growth
  • AXSM N/A
  • MCY N/A
  • EPS
  • AXSM N/A
  • MCY 10.08
  • Revenue
  • AXSM $338,457,000.00
  • MCY $5,470,287,000.00
  • Revenue This Year
  • AXSM $44.77
  • MCY N/A
  • Revenue Next Year
  • AXSM $67.70
  • MCY $6.09
  • P/E Ratio
  • AXSM N/A
  • MCY $4.85
  • Revenue Growth
  • AXSM 51.47
  • MCY 24.14
  • 52 Week Low
  • AXSM $64.11
  • MCY $37.89
  • 52 Week High
  • AXSM $105.00
  • MCY $80.72
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 43.66
  • MCY 16.71
  • Support Level
  • AXSM $79.19
  • MCY $44.19
  • Resistance Level
  • AXSM $87.53
  • MCY $66.35
  • Average True Range (ATR)
  • AXSM 4.37
  • MCY 2.35
  • MACD
  • AXSM -0.02
  • MCY -2.09
  • Stochastic Oscillator
  • AXSM 61.27
  • MCY 19.30

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: